Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.

Ensign LM, Cone R, Hanes J.

Adv Drug Deliv Rev. 2012 May 1;64(6):557-70. doi: 10.1016/j.addr.2011.12.009. Epub 2011 Dec 24. Review.

2.

Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse.

Maisel K, Ensign L, Reddy M, Cone R, Hanes J.

J Control Release. 2015 Jan 10;197:48-57. doi: 10.1016/j.jconrel.2014.10.026. Epub 2014 Nov 4.

3.

Polymeric micelles for oral drug delivery.

Gaucher G, Satturwar P, Jones MC, Furtos A, Leroux JC.

Eur J Pharm Biopharm. 2010 Oct;76(2):147-58. doi: 10.1016/j.ejpb.2010.06.007. Epub 2010 Jun 19. Review.

PMID:
20600891
4.

Polymeric nanoparticle drug delivery technologies for oral delivery applications.

Pridgen EM, Alexis F, Farokhzad OC.

Expert Opin Drug Deliv. 2015;12(9):1459-73. doi: 10.1517/17425247.2015.1018175. Epub 2015 Mar 26. Review.

5.

Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.

Yun Y, Cho YW, Park K.

Adv Drug Deliv Rev. 2013 Jun 15;65(6):822-32. doi: 10.1016/j.addr.2012.10.007. Epub 2012 Nov 2. Review.

6.

Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.

Yuan H, Chen CY, Chai GH, Du YZ, Hu FQ.

Mol Pharm. 2013 May 6;10(5):1865-73. doi: 10.1021/mp300649z. Epub 2013 Apr 5.

PMID:
23495754
7.

pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.

Wang XQ, Zhang Q.

Eur J Pharm Biopharm. 2012 Oct;82(2):219-29. doi: 10.1016/j.ejpb.2012.07.014. Epub 2012 Aug 3. Review.

PMID:
22885229
8.

The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems.

Sarparanta MP, Bimbo LM, Mäkilä EM, Salonen JJ, Laaksonen PH, Helariutta AM, Linder MB, Hirvonen JT, Laaksonen TJ, Santos HA, Airaksinen AJ.

Biomaterials. 2012 Apr;33(11):3353-62. doi: 10.1016/j.biomaterials.2012.01.029. Epub 2012 Jan 29.

PMID:
22285465
9.

Nanocarrier systems for oral drug delivery: do we really need them?

Bernkop-Schnürch A.

Eur J Pharm Sci. 2013 May 13;49(2):272-7. doi: 10.1016/j.ejps.2013.03.008. Epub 2013 Mar 26. Review.

PMID:
23537503
10.

Polymeric micelles for oral drug administration enabling locoregional and systemic treatments.

Simões SM, Figueiras AR, Veiga F, Concheiro A, Alvarez-Lorenzo C.

Expert Opin Drug Deliv. 2015 Feb;12(2):297-318. doi: 10.1517/17425247.2015.960841. Epub 2014 Sep 17. Review.

PMID:
25227130
11.

Oral delivery of proteins by biodegradable nanoparticles.

Bakhru SH, Furtado S, Morello AP, Mathiowitz E.

Adv Drug Deliv Rev. 2013 Jun 15;65(6):811-21. doi: 10.1016/j.addr.2013.04.006. Epub 2013 Apr 20. Review.

PMID:
23608641
12.

Engineering strategies to enhance nanoparticle-mediated oral delivery.

Yamanaka YJ, Leong KW.

J Biomater Sci Polym Ed. 2008;19(12):1549-70. doi: 10.1163/156856208786440479. Review.

PMID:
19017470
13.

Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery.

Leonaviciute G, Bernkop-Schnürch A.

Expert Opin Drug Deliv. 2015;12(11):1703-16. doi: 10.1517/17425247.2015.1068287. Epub 2015 Aug 24. Review.

PMID:
26477549
14.

Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?

Diab R, Jaafar-Maalej C, Fessi H, Maincent P.

AAPS J. 2012 Dec;14(4):688-702. doi: 10.1208/s12248-012-9377-y. Epub 2012 Jul 6. Review.

15.

Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.

Date AA, Hanes J, Ensign LM.

J Control Release. 2016 Jun 9. pii: S0168-3659(16)30381-9. doi: 10.1016/j.jconrel.2016.06.016. [Epub ahead of print]

PMID:
27292178
16.

Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.

Chen D, Xia D, Li X, Zhu Q, Yu H, Zhu C, Gan Y.

Int J Pharm. 2013 Jun 5;449(1-2):1-9. doi: 10.1016/j.ijpharm.2013.04.002. Epub 2013 Apr 11.

PMID:
23583840
17.

Multifunctional matrices for oral peptide delivery.

Bernkop-Schnürch A, Walker G.

Crit Rev Ther Drug Carrier Syst. 2001;18(5):459-501. Review.

PMID:
11763498
18.

Polymeric particulates to improve oral bioavailability of peptide drugs.

Delie F, Blanco-Príeto MJ.

Molecules. 2005 Jan 31;10(1):65-80. Review.

19.

Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.

Hunter AC, Elsom J, Wibroe PP, Moghimi SM.

Maturitas. 2012 Sep;73(1):5-18. doi: 10.1016/j.maturitas.2012.05.014. Epub 2012 Jun 17. Review.

PMID:
22709523
20.

Mucus as a barrier to drug delivery – understanding and mimicking the barrier properties.

Boegh M, Nielsen HM.

Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):179-86. doi: 10.1111/bcpt.12342. Epub 2014 Dec 23. Review.

Items per page

Supplemental Content

Write to the Help Desk